Deep Brain Stimulation for Parkinson's Disease: Currents Status and Emerging Concepts

Area of Science:

• Neurology
• Neurosurgery
• Biomedical Engineering

Background:

• Deep brain stimulation (DBS) technology has advanced significantly, becoming safer and more user-friendly.
• Early-stage Parkinson's disease is now an approved indication for DBS, supported by Class-I evidence from the EARLY-STIM trial.
• DBS efficacy and safety are comparable in both elderly and younger Parkinson's disease patients.

Purpose of the Study:

• To review the expanded clinical applications and technological advancements in DBS for Parkinson's disease.
• To discuss novel DBS targets beyond the subthalamic nucleus and globus pallidus internus.
• To examine the long-term efficacy and safety of DBS in managing Parkinson's disease symptoms.

Main Methods:

• Review of clinical trial data, including the EARLY-STIM trial.
• Analysis of studies investigating new DBS targets (e.g., PPN, PSA, CM/Pf, SNr).
• Evaluation of technological innovations such as current steering, directional leads, and closed-loop DBS.

Main Results:

• Bilateral STN-DBS demonstrates benefits for both motor and non-motor symptoms.
• New targets are emerging for symptom alleviation in Parkinson's disease.
• Long-term data confirm sustained motor benefits of DBS, concurrent with ongoing clinical progression.

Conclusions:

• DBS is a well-established and evolving therapeutic option for Parkinson's disease across various stages.
• Technological advancements aim to enhance DBS safety and longevity.
• Continued research and discussion are necessary to fully understand DBS's long-term impact on Parkinson's disease progression.